Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

366 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells.
Dajon M, Iribarren K, Petitprez F, Marmier S, Lupo A, Gillard M, Ouakrim H, Victor N, Vincenzo DB, Joubert PE, Kepp O, Kroemer G, Alifano M, Damotte D, Cremer I. Dajon M, et al. Among authors: kepp o. Oncoimmunology. 2018 Oct 11;8(1):e1505174. doi: 10.1080/2162402X.2018.1505174. eCollection 2019. Oncoimmunology. 2018. PMID: 30546943 Free PMC article.
Molecular characteristics of immunogenic cancer cell death.
Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G. Tesniere A, et al. Among authors: kepp o. Cell Death Differ. 2008 Jan;15(1):3-12. doi: 10.1038/sj.cdd.4402269. Epub 2007 Nov 16. Cell Death Differ. 2008. PMID: 18007663 Review.
To die or not to die: that is the autophagic question.
Galluzzi L, Vicencio JM, Kepp O, Tasdemir E, Maiuri MC, Kroemer G. Galluzzi L, et al. Among authors: kepp o. Curr Mol Med. 2008 Mar;8(2):78-91. doi: 10.2174/156652408783769616. Curr Mol Med. 2008. PMID: 18336289 Review.
Immunogenic cancer cell death: a key-lock paradigm.
Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, Schlemmer F, Zitvogel L, Kroemer G. Tesniere A, et al. Among authors: kepp o. Curr Opin Immunol. 2008 Oct;20(5):504-11. doi: 10.1016/j.coi.2008.05.007. Epub 2008 Jun 23. Curr Opin Immunol. 2008. PMID: 18573340 Review.
Targeting p53 to mitochondria for cancer therapy.
Galluzzi L, Morselli E, Kepp O, Tajeddine N, Kroemer G. Galluzzi L, et al. Among authors: kepp o. Cell Cycle. 2008 Jul 1;7(13):1949-55. doi: 10.4161/cc.7.13.6222. Cell Cycle. 2008. PMID: 18642442 Review.
Mutant p53 protein localized in the cytoplasm inhibits autophagy.
Morselli E, Tasdemir E, Maiuri MC, Galluzzi L, Kepp O, Criollo A, Vicencio JM, Soussi T, Kroemer G. Morselli E, et al. Among authors: kepp o. Cell Cycle. 2008 Oct;7(19):3056-61. doi: 10.4161/cc.7.19.6751. Epub 2008 Oct 6. Cell Cycle. 2008. PMID: 18818522 Free article.
p53 represses autophagy in a cell cycle-dependent fashion.
Tasdemir E, Maiuri MC, Orhon I, Kepp O, Morselli E, Criollo A, Kroemer G. Tasdemir E, et al. Among authors: kepp o. Cell Cycle. 2008 Oct;7(19):3006-11. doi: 10.4161/cc.7.19.6702. Epub 2008 Oct 30. Cell Cycle. 2008. PMID: 18838865
The immunogenicity of tumor cell death.
Kepp O, Tesniere A, Zitvogel L, Kroemer G. Kepp O, et al. Curr Opin Oncol. 2009 Jan;21(1):71-6. doi: 10.1097/CCO.0b013e32831bc375. Curr Opin Oncol. 2009. PMID: 19125021 Review.
366 results